About Antria
Antria is a company based in Greensburg (United States) founded in 2012.. Antria has raised $1.44 million across 1 funding round. Antria offers products and services including Clinical Research Services, Drug Discovery Services, and Medical Device Development. Antria operates in a competitive market with competitors including ViaCyte, Neurona Therapeutics, DiscGenics, EpiBone and Gamida Cell, among others.
- Headquarter Greensburg, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.44 M (USD)
in 1 rounds
-
Latest Funding Round
$1.44 M (USD), Seed
Jan 24, 2013
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antria
Antria offers a comprehensive portfolio of products and services, including Clinical Research Services, Drug Discovery Services, and Medical Device Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Conducts trials to advance medical knowledge and treatments.
Develops new drugs for various medical conditions.
Creates devices to enhance patient care and outcomes.
Unlock access to complete
Unlock access to complete
Funding Insights of Antria
Antria has successfully raised a total of $1.44M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.44 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.4M
-
First Round
First Round
(24 Jan 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2013 | Amount | Seed - Antria | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Antria
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Antria
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Antria Comparisons
Competitors of Antria
Antria operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaCyte, Neurona Therapeutics, DiscGenics, EpiBone and Gamida Cell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell therapy for diabetes is developed from stem cells.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies are developed for intractable neurological diseases.
|
|
| domain | founded_year | HQ Location |
Tissue engineering company utilizing a proprietary stem technology to treat degenerative disc disease.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Cell therapies for cancer and serious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Aurion Biotech is focused on developing advanced therapies for ocular diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Antria
When was Antria founded?
Antria was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Antria located?
Antria is headquartered in Greensburg, United States. It is registered at Greensburg, Pennsylvania, United States.
Is Antria a funded company?
Antria is a funded company, having raised a total of $1.44M across 1 funding round to date. The company's 1st funding round was a Seed of $1.44M, raised on Jan 24, 2013.
What does Antria do?
Antria develops products comprising of autologous adipose-derived stem cells. As of Feb 2016, the company has completed phase II clinical trials for facial fat grafting. It has additional programs for breast augmentation, scar and acne treatment, critical limb ischemia, chronic wounds, non-healing fractures, congestive heart failure, osteoarthritis, rheumatoid arthritis and multiple sclerosis. Antria also provides its services to biotechnology companies and the research industry.
Who are the top competitors of Antria?
Antria's top competitors include EpiBone, Neurona Therapeutics and Gamida Cell.
What products or services does Antria offer?
Antria offers Clinical Research Services, Drug Discovery Services, and Medical Device Development.